MPH Health Care AG

FSX:93M1.DE

18.4 (EUR) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q2
Revenue 84.1567.1520.116.5830.2673.7270.634-9.3130.2936.471-0.161-12.85857.70426.4317.382.8486.042150.178112.708101.672117.576114.46112.384106.4199.29872.76172.76156.20756.20731.1131.11
Cost of Revenue 0-26.937-0.2310.0350.0170.140.2080.2680.1660.2720.06900006.8936.876133.727102.488.792108.668105.559104.439100.25885.50664.34264.34247.23747.23725.94325.943
Gross Profit 84.15634.0890.3416.5490.253.5870.426-9.5810.1266.199-0.23-12.85857.70426.4317.38-4.045-0.83416.45110.30812.8818.9088.97.9466.15213.7928.4188.4188.978.975.1665.166
Gross Profit Ratio 14.7663.0940.9950.9380.9620.6721.0290.4320.9581.4271111-1.42-0.1380.110.0910.1270.0760.0780.0710.0580.1390.1160.1160.160.160.1660.166
Reseach & Development Expenses 00.0940.0410.040.040.040.040.040.0350.011000000000000000000000
General & Administrative Expenses 0.4270.6710.4710.5640.4230.5260.3980.4340.4070.4930.4410.7660.380.8560.3210000000000000000
Selling & Marketing Expenses 0-0.659-0.464-0.55-0.413-0.514-0.39-0.426-0.398-0.484000000000000000000000
SG&A 0.4270.6710.4710.5640.0110.0120.0080.0080.0090.0090.4410.7660.380.8560.3210.1420.4164.8063.526.47905.818000000000
Other Expenses 7.9890-00-0-000-00-18.17900000000000000000000
Operating Expenses 8.41511.56115.78235.70536.75121.6690.58935.68638.7151.74318.1796.1851.028.1749.69951.64413.56867.7235.2038.1492.7282.0942.2695.021-3.1593.0993.0993.7723.7722.0932.093
Operating Income 75.74146.792-15.59466.064-35.995-32.41323.457-37.723-32.65629.313-18.409-13.60957.33725.9777.0829.396-1.5048.0235.1044.7326.186.8065.6774.43710.6525.3195.3195.1985.1983.0733.073
Operating Income Ratio 0.96.542-141.34610.035-135.034-8.69636.9844.051-111.614.53114.3261.0580.9940.9830.963.299-0.2490.0530.0450.0470.0530.0590.0510.0420.1070.0730.0730.0920.0920.0990.099
Total Other Income Expenses Net -0.240.598-0.05-0.054-0.541-0.5630.33-0.546-0.5260.394-0.248-5.681-0.705-0.12-9.44851.87921.13174.954-0.823-2.531-3.4713.019-0.5176.022-0.647-0.373-0.373-0.143-0.143-0.15-0.15
Income Before Tax 75.546.401-15.64466.009-0-00-0-00-18.658-19.28956.63134.485-2.36661.27519.88182.9974.2813.8715.4386.1015.1610.45910.0054.9464.9465.0555.0552.9242.924
Income Before Tax Ratio 0.8976.488-141.79910.027-0-000-00115.8691.50.9811.305-0.32121.5153.290.5530.0380.0380.0460.0530.0460.0980.1010.0680.0680.090.090.0940.094
Income Tax Expense 0.9760.461-0.2380.9-0-00-0-00-0.420.4070.7240.4320.1680.8250.2651.1821.9960.0320.8882.8410.9281.7920.270.6240.6240.4910.4910.3840.384
Net Income 74.52444.951-15.40665.1094.2814.2814.2814.2814.2814.281-18.237-18.88255.90734.053-2.19860.4519.61680.3032.2850.44.552.2144.2327.7476.9674.3224.3224.5644.5642.542.54
Net Income Ratio 0.8866.285-139.6469.8916.0621.1496.75-0.4614.6330.662113.2591.4690.9691.288-0.29821.2253.2470.5350.020.0040.0390.0190.0380.0730.070.0590.0590.0810.0810.0820.082
EPS 17.4110.5-3.615.21111110.99-4.26-4.413.18.17-0.514.064.618.760.530.0951.120.551.060.4601.051.051.21.20.650.65
EPS Diluted 17.4110.5-3.615.21111110.99-4.26-4.413.18.17-0.514.064.618.760.530.0951.120.551.040.4601.051.051.21.20.650.65
EBITDA 83.74246.804-0.11629.835-0.541-0.56323.861-0.546-0.52629.993-18.406-13.57457.34725.9887.09215.405-1.49418.0255.9985.6647.0777.7156.495.09911.0035.5065.5065.3225.3223.1923.192
EBITDA Ratio 0.9956.544-1.0534.532-2.03-0.15137.620.059-1.7964.635114.311.0560.9940.9830.9615.409-0.2470.120.0530.0560.060.0670.0580.0480.1110.0760.0760.0950.0950.1030.103